GASTROINTESTINAL RADIOFREQUENCY ABLATION SYSTEMS

The goal of intervention is to prevent disease progression([FOOTNOTE=Whiteman DC, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 2015; 30: 804-20.],[ANCHOR=],[LINK=])

The Barrx™ system is designed to remove the Barrett's epithelium in a short, well-tolerated endoscopic procedure and offers an alternative to "watchful waiting" for patients with intestinal metaplasia, low-grade, and high-grade dysplasia.

The Barrx™ 360 express RFA balloon catheter and the Barrx™ channel RFA endoscopic catheter simulator application is now available on the Apple App Store®.

This educational application offers an interactive experience that provides useful information about procedural steps, handling, and usage of these devices — in a 3D simulated environment.^† This app is suitable for iPad®, and is free to download and install.

View the App

Watch this online webinar on Barrett's Esophagus.

Watch the Online Webinar

Medtronic is committed to saving patients’ lives by helping you work towards better patient outcomes and prevent disease progression, with our reliable treatments.

Download the value analysis dossier

Barrx™ 360 Express RFA Balloon Catheter

Barrx™ Channel RFA Endoscopic Catheter

Barrx™ RFA Focal Catheters

Barrx™ Radiofrequency Ablation System

Barrx™ RFA Accessories

Overview

We offer a comprehensive portfolio of radiofrequency ablation solutions to treat Barrett's esophagus and other GI tract diseases.([FOOTNOTE=Phoa KN, van Vilsteren FG, Pouw RE, et al. Radiofrequency ablation in Barrett's esophagus with confirmed low-grade dysplasia: interim results of a European multicenter randomized controlled trial (SURF). Gastroenterology. 2013; 144:S-187.],[ANCHOR=],[LINK=])^,([FOOTNOTE=Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esphagus with dysplasia. N Engl J Med. 2009 May 28;360(22):2277-88.],[ANCHOR=],[LINK=])^,([FOOTNOTE=van Vilsteren FG, Pouw RE, Seewald S, Alvarez HL, Sondermeijer CM, Visser M, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's esophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut. 2011; 60:765-73.],[ANCHOR=],[LINK=])^,([FOOTNOTE=Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010;42:781-9],[ANCHOR=],[LINK=])^,([FOOTNOTE=Phoa KN, Pouw RE, van Vilsteren FG, et al. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013 Jul; 145(1):96-104.],[ANCHOR=],[LINK=])^,([FOOTNOTE=Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. AM J Gastroenterol. 2011;106:1899-908.],[ANCHOR=],[LINK=]) With focal and circumferential catheters, plus advanced features designed to increase procedural efficiency, these innovations provide the flexibility needed to meet the unique needs of each patient.

Early detection and treatment of chronic GI diseases and cancers can be key to better outcomes.

Explore our portfolio

Stay up to date with our latest videos

Check our YouTube channel for more information on our products and services.

Gastrointestinal & Hepatology Videos

Join the discussion

Stay up to date with new products, innovative stories and events.

Medtronic LinkedIn

Interested in learning more?

Contact us to learn more about how the Barrx™ RF Ablation System can enable you to effectively treat Barrett's Oesophagus patients with predictable results.

Emprint HP Ablation System with Thermosphere Technology

Contact a representative

† This app is for simulation purposes only and does not reflect actual use of the device in a clinical setting with actual equipment. It is also not to be used for training purposes but for demonstration only. While every reasonable precaution has been taken in the preparation of this guide, Medtronic assumes no responsibility for errors or omissions, nor for the uses made of the materials contained herein and the decisions based on such use. This document does not contain all of the information necessary for the proper care and treatment of patients. As such, no individual may rely on the information presented herein in forming a comprehensive treatment program or in treating any patient. No warranties are made, expressed or implied, with regard to the contents of this work or to its applicability to specific patients or circumstances. Medtronic shall not be liable for direct, indirect, special, incidental or consequential damages arising out of the use or inability to use the contents of this guide.

Select your country/language

Contact & Support

GASTROINTESTINAL RADIOFREQUENCY ABLATION SYSTEMS

The goal of intervention is to prevent disease progression([FOOTNOTE=Whiteman DC, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 2015; 30: 804-20.],[ANCHOR=],[LINK=])

BARRX™ RFA SIMULATOR APP

Barrx™ radiofrequency ablation system simulator application for iPad®

View the App

Barrett's Esophagus: An undiagnosed disease

Watch the Online Webinar